Fionda, Laura
 Distribuzione geografica
Continente #
NA - Nord America 1.213
EU - Europa 849
AS - Asia 498
AF - Africa 36
SA - Sud America 18
OC - Oceania 1
Totale 2.615
Nazione #
US - Stati Uniti d'America 1.187
IT - Italia 473
SG - Singapore 153
IN - India 102
CN - Cina 81
UA - Ucraina 46
DE - Germania 45
GB - Regno Unito 40
SE - Svezia 37
FR - Francia 34
TR - Turchia 33
JP - Giappone 29
NL - Olanda 29
ID - Indonesia 26
TG - Togo 23
FI - Finlandia 22
HK - Hong Kong 21
CH - Svizzera 17
CA - Canada 16
ES - Italia 13
BG - Bulgaria 12
AT - Austria 10
PH - Filippine 10
IE - Irlanda 9
VN - Vietnam 8
AL - Albania 7
MK - Macedonia 7
AR - Argentina 6
CY - Cipro 6
BE - Belgio 5
BR - Brasile 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
IL - Israele 5
KR - Corea 5
LI - Liechtenstein 5
RS - Serbia 5
SC - Seychelles 5
MX - Messico 4
PL - Polonia 4
RO - Romania 4
TH - Thailandia 4
CO - Colombia 3
GR - Grecia 3
MY - Malesia 3
PE - Perù 3
PK - Pakistan 3
RU - Federazione Russa 3
TW - Taiwan 3
UG - Uganda 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
DK - Danimarca 2
HU - Ungheria 2
IS - Islanda 2
LY - Libia 2
MA - Marocco 2
SA - Arabia Saudita 2
AU - Australia 1
BZ - Belize 1
CL - Cile 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
IR - Iran 1
LT - Lituania 1
LU - Lussemburgo 1
NO - Norvegia 1
PT - Portogallo 1
UZ - Uzbekistan 1
Totale 2.615
Città #
Rome 135
Fairfield 131
Singapore 128
Chandler 125
Ashburn 90
Milan 60
Woodbridge 57
Seattle 54
Cambridge 53
Houston 52
Santa Clara 52
Wilmington 46
New York 31
Princeton 27
San Paolo di Civitate 27
Istanbul 26
Jakarta 23
Lomé 23
Lawrence 21
Dearborn 20
Ann Arbor 17
Helsinki 16
Hong Kong 16
Paris 16
Bengaluru 15
Rotterdam 14
Frankfurt am Main 13
Millbury 13
Boardman 12
Sofia 12
Boston 10
San Diego 10
Tokyo 10
Chicago 9
Dublin 9
Los Angeles 9
Beijing 8
Plano 8
Toronto 8
Andover 7
Concord 7
Fremont 7
Nanjing 7
Ponzano Veneto 7
San Mateo 7
Shanghai 7
Stockholm 7
Fasano 6
Hyderabad 6
Limassol 6
Naples 6
Shenzhen 6
Songjiang 6
Vienna 6
Barcelona 5
Bari 5
Bremen 5
Florence 5
Hanoi 5
Holon 5
Izmir 5
Manchester 5
Norwalk 5
Palermo 5
Pune 5
Bangkok 4
Boulogne-Billancourt 4
Dallas 4
Des Moines 4
Erie 4
Hangzhou 4
London 4
Mahé 4
Oxford 4
Sordio 4
Tirana 4
Turin 4
Zurich 4
Alajuela 3
Almora 3
Brent 3
Brussels 3
Cascina 3
Chennai 3
Falkenstein 3
Grosseto 3
Gulfport 3
Hillsborough 3
Kyoto 3
Leighton Buzzard 3
Lima region 3
Mexico City 3
Paju 3
Portland 3
Prilep 3
Salt Lake City 3
Woodstock 3
Wuhan 3
Xi'an 3
Atlanta 2
Totale 1.676
Nome #
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study 296
Minimal Symptom Expression' in Patients With Acetylcholine Receptor Antibody-Positive Refractory Generalized Myasthenia Gravis Treated With Eculizumab 169
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN). a phase 3, randomised, double-blind, placebo-controlled, multicentre study 163
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT). a multicentre, randomised, placebo-controlled, phase 3 trial 158
Eculizumab improves fatigue in refractory generalized myasthenia gravis 132
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension 116
Nerve high-resolution ultrasonography in peripheral nerve injuries associated with supracondylar humeral fractures in children 92
Cutaneous silent period recordings in demyelinating and axonal polyneuropathies 90
Multifocal motor neuropathy following treatment with adalimumab for ulcerative colitis 87
Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up 86
A 34-year longitudinal study on long-term cardiac outcomes in DM1 patients with normal ECG at baseline at an Italian clinical centre 85
Nerve high resolution ultrasonography in Tangier disease 85
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis 85
Widening the phenotypical spectrum of EGR2-related CMT: unusual phenotype for R409W mutation 84
Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study 83
Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of Myasthenia-Myositis association from a large cohort of patients 70
Consistent improvement with eculizumab across muscle groups in myasthenia gravis 61
Gender effect on cardiac involvement in myotonic dystrophy type 1 60
Skin biopsy and quantitative sensory assessment in an Italian cohort of ATTRv patients with polyneuropathy and asymptomatic carriers: possible evidence of early non-length dependent denervation 60
Quantitative sensory testing and skin biopsy findings in late‐onset ATTRv pre‐symptomatic carriers: relationships with predicted time of disease onset (PADO) 59
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials 59
Muscle MRI in immune-mediated necrotizing myopathy (IMNM). implications for clinical management and treatment strategies 58
Novel ACTA1 mutation causes late-presenting nemaline myopathy with unusual dark cores 55
Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients 48
Marked efficacy of Rituximab in multifocal motor neuropathy associated with chronic lymphocytic leukemia 46
High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP 43
Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy 40
Distal upper limb involvement in myasthenia-myositis association 38
Prominent mitochondrial pathology in a case of refractory dermatomyositis: coincidence or concause? 37
Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study 36
Marked efficacy of rituximab in multifocal motor neuropathy associated with chronic lymphocytic leukemia 34
Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) 31
Chronic inflammatory demyelinating polyneuropathy and HEV antibody status: A case-control study from Lazio, Italy 27
Nerve high-resolution ultrasound in a 2-years follow-up of radial nerve palsy related to humeral shaft fractures 23
Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors 22
Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis (Quality of Life Research, (2019), 28, 8, (2247-2254), 10.1007/s11136-019-02148-2) 22
Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis. A subgroup analysis of the REGAIN open-label extension study 18
Clinical course of neurologic adverse events associated with immune checkpoint inhibitors focus on chronic toxicities 10
null 4
null 3
Totale 2.775
Categoria #
all - tutte 9.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.039


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020194 0 0 0 0 0 41 43 31 28 13 20 18
2020/2021264 17 12 47 17 11 26 18 11 32 34 21 18
2021/2022372 45 12 29 20 44 23 22 30 15 16 77 39
2022/2023532 53 92 17 64 51 53 30 45 37 16 45 29
2023/2024661 16 46 30 37 51 74 36 87 34 98 80 72
2024/2025568 84 163 66 97 105 53 0 0 0 0 0 0
Totale 2.775